Soluble urokinase plasminogen activator receptor (suPAR) as a prognostic marker of mortality in healthy, general and patient populations: protocol for a systematic review and meta-analysis

Soluble urokinase plasminogen activator receptor (suPAR) as a prognostic marker of mortality in healthy, general and patient populations: protocol for a systematic review and meta-analysis

Introduction: Chronic inflammation is increasingly recognized as a major contributor to disease, disability and eventually death, but measure the degree of chronic inflammation remains non-saints, making it difficult to relate to chronic inflammation and death. Soluble urokinase plasminogen activator receptor (Supar), an emerging biomarker of chronic inflammation, has been proposed as a prognostic biomarker associated with the future occurrence of chronic diseases and mortality in general and patient populations.

precise prognostic biomarkers are important because they can help improve risk stratification in clinical settings and provide guidance in the treatment or lifestyle decisions as well as in the design of randomized trials. Here, we would like to summarize the evidence on the overall relationship of biomarker Supar death in the healthy population, the public and patients throughout the disease.


Methods and analysis: The search will be performed using Medline, Embase and Scopus databases from their inception to June 3, 2020 to identify studies investigating the ‘Supar’ and ‘death’. Observational studies and a control group of the study interventions were written in English or Danish will be included. Tools ‘Quality At Prognosis Studies’ will be used to assess the risk of bias of included studies. measures unadjusted and adjusted mortality outcomes (eg, risk ratio, OR, HR) with 95% CI are extracted to a healthy individual, general and patient populations. The primary outcome was all-cause mortality in any given follow-up. subgroup analysis will be based on the time of the results, the cause of death, type of population, adjusting for conventional risk factors and markers of inflammation.


Ethics and deployment: This systematic review will synthesize evidence on Supar use as a prognostic marker for mortality. The results will be disseminated by publications in peer-reviewed journals. Data used will be obtained from published studies, and therefore ethics approval is not required for this systematic review.

Soluble urokinase plasminogen activator receptor (suPAR) as a prognostic marker of mortality in healthy, general and patient populations: protocol for a systematic review and meta-analysis
Soluble urokinase plasminogen activator receptor (suPAR) as a prognostic marker of mortality in healthy, general and patient populations: protocol for a systematic review and meta-analysis

Helicobacter pylori colonization Drives Urokinase Receptor (Upar) The expression in murine gastric epithelium During the Early Pathogenesis

Background: Persistent infection with Helicobacter pylori is the most important risk factor for gastric cancer. The urokinase receptor (Upar) upregulated in lesions and inflammation keep cancer invasion. evidence of H. pylori colonization tends to be correlated with increased expression of Upar in human gastric epithelium, but the link has not been established proximate cause in vivo; (2) Method: In a mouse model of H. pylori-induced gastritis, we investigate the emergence of Upar temporal protein expression in gastric mucosa in response to H. pylori (SS1 strain) infection; (3)

Results: We observed intense Upar foveolar immunoreactivity in the epithelial cells of the corpus of the stomach due to de novo synthesis, compared with non-infected animals. Upar induction is a response to the very beginning, but increased progressively over time as do the infiltration of immune cells. Eradication of H. pylori infections with antimicrobial therapy causes regression Upar expression to basic physiological level.

UPA Antibody

F51094-0.4ML 0.4 ml
EUR 322.15
Description: PLAU, a member of the peptidase family S1, is a potent plasminogen activator and is clinically used for therapy of thrombolytic disorders. PLAU specifically cleaves the Arg-|-Val bond in plasminogen to form plasmin. The protein is found in high and low molecular mass forms. Each consists of two chains, A and B. The high molecular mass form contains a long chain A. Cleavage occurs after residue 155 in the low molecular mass form to yield a short A1 chain. The protein is used in Pulmonary Embolism (PE) to initiates fibrinolysis. Structurally, PLAU contains 1 EGF-like domain and 1 kringle domain.

uPA Receptor

MBS8578525-01mL 0.1mL
EUR 345

uPA Receptor

MBS8578525-01mLAF405L 0.1mL(AF405L)
EUR 565

uPA Receptor

MBS8578525-01mLAF405S 0.1mL(AF405S)
EUR 565

uPA Receptor

MBS8578525-01mLAF610 0.1mL(AF610)
EUR 565

uPA Receptor

MBS8578525-01mLAF635 0.1mL(AF635)
EUR 565

uPA Antibody

MBS9509094-005mL 0.05mL
EUR 285

uPA Antibody

MBS9509094-01mL 0.1mL
EUR 385

uPA Antibody

MBS9509094-5x01mL 5x0.1mL
EUR 1590

uPA Antibody

R12-2403-100ul 100μl
EUR 217
Description: uPA Rabbit Polyclonal Antibody

uPA Antibody

R12-2403-50ul 50μl
EUR 143.5
Description: uPA Rabbit Polyclonal Antibody

uPA Mouse mAb

E2222809 100ul
EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

uPA Rabbit mAb

E2R381717 100ul
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

Anti Murine uPA

MBS480193-1mg 1mg
EUR 1105

Anti Murine uPA

MBS480193-5x1mg 5x1mg
EUR 4760

anti- uPA antibody

FNab09267 100µg
EUR 606.3
Description: Antibody raised against uPA

Recombinant Human UPA

MBS7613929-005mg 0.05mg
EUR 345

Recombinant Human UPA

MBS7613929-02mg 0.2mg
EUR 635

Recombinant Human UPA

MBS7613929-1mg 1mg
EUR 1800

Recombinant Human UPA

MBS7613929-5x1mg 5x1mg
EUR 6955

uPA Recombinant Protein

91-360 0.05 mg
EUR 852.9
Description: Recombinant Human Urokinase-Type Plasminogen Activator is a serine protease, which specifically cleaves the zymogen plasminogen to form the active enzyme plasmin. Urokinase-Type Plasminogen Activator is a potent marker of invasion and metastasis in many human cancers associated with breast, colon, stomach, bladder, brain, ovary and endometrium. Human Urokinase-Type Plasminogen Activator is initially synthesized as 431 amino acid precursor with a N-terminal signal peptide residues. The single chain molecule is processed into a disulfide-linked two-chain molecule. There exists two forms A chain, the long A chain contains an EGF-like domain that is responsible for binding of the uPA receptor. The B chain corresponds to the catalytic domain.

uPA Polyclonal Antibody

ABP55603-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of uPA from Human. This uPA antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human uPA

uPA Polyclonal Antibody

ABP55603-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of uPA from Human. This uPA antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human uPA

uPA Polyclonal Antibody

ABP55603-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of uPA from Human. This uPA antibody is for IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human uPA

uPA Polyclonal Antibody

E20-74823 100ug
EUR 225
Description: Available in various conjugation types.

uPA Polyclonal Antibody

BT-AP09424-100ul 100ul Ask for price
Description: PLAU (plasminogen activator, urokinase) encodes a secreted serine protease that converts plasminogen to plasmin. The encoded preproprotein is proteolytically processed to generate A and B polypeptide chains. These chains associate via a single disulfide bond to form the catalytically inactive high molecular weight urokinase-type plasminogen activator (HMW-uPA). HMW-uPA can be further processed into the catalytically active low molecular weight urokinase-type plasminogen activator (LMW-uPA). This low molecular weight form does not bind to the urokinase-type plasminogen activator receptor. Mutations in PLAU may be associated with Quebec platelet disorder and late-onset Alzheimer's disease. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed.

uPA Polyclonal Antibody

BT-AP09424-20ul 20ul Ask for price
Description: PLAU (plasminogen activator, urokinase) encodes a secreted serine protease that converts plasminogen to plasmin. The encoded preproprotein is proteolytically processed to generate A and B polypeptide chains. These chains associate via a single disulfide bond to form the catalytically inactive high molecular weight urokinase-type plasminogen activator (HMW-uPA). HMW-uPA can be further processed into the catalytically active low molecular weight urokinase-type plasminogen activator (LMW-uPA). This low molecular weight form does not bind to the urokinase-type plasminogen activator receptor. Mutations in PLAU may be associated with Quebec platelet disorder and late-onset Alzheimer's disease. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed.

uPA Polyclonal Antibody

BT-AP09424-50ul 50ul Ask for price
Description: PLAU (plasminogen activator, urokinase) encodes a secreted serine protease that converts plasminogen to plasmin. The encoded preproprotein is proteolytically processed to generate A and B polypeptide chains. These chains associate via a single disulfide bond to form the catalytically inactive high molecular weight urokinase-type plasminogen activator (HMW-uPA). HMW-uPA can be further processed into the catalytically active low molecular weight urokinase-type plasminogen activator (LMW-uPA). This low molecular weight form does not bind to the urokinase-type plasminogen activator receptor. Mutations in PLAU may be associated with Quebec platelet disorder and late-onset Alzheimer's disease. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed.

uPA Polyclonal Antibody

E44H03060 100ul
EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

uPA Polyclonal Antibody

MBS8525804-01mg 0.1mg
EUR 305

uPA Polyclonal Antibody

MBS8525804-01mLAF405L 0.1mL(AF405L)
EUR 465

uPA Polyclonal Antibody

MBS8525804-01mLAF405S 0.1mL(AF405S)
EUR 465

uPA Polyclonal Antibody

MBS8525804-01mLAF610 0.1mL(AF610)
EUR 465

uPA Polyclonal Antibody

MBS8525804-01mLAF635 0.1mL(AF635)
EUR 465

uPAR Antibody uPA Receptor

R30410 100 ug
EUR 356.15
Description: PLAUR (Plasminogen activator receptor, urokinase-type), also known as uPAR or CD87, is multidomain glycoprotein tethered to the cell membrane with a glycosylphosphotidylinositol(GPI) anchor. It consists of three different domains of the Ly-6/uPAR/alpha-neurotoxin family. The protein was originally identified as a saturable binding site for urokinase on the cell surface. The gene plays an important role in many normal as well as pathologic processes. It is localized to 19q13.31. uPAR is a part of the plasminogen activation system, which in the healthy body is involved in tissue reorganization events such as mammary gland involution and wound healing. It binds urokinase and thus restricts plasminogen activation to the immediate vicinity of the cell membrane, indicating it is an important player in the regulation of this process. In human coronary artery vascular smooth muscle cells, UPA stimulates cell migration via a uPAR signaling complex containing TYK2 and phosphatidylinositol 3-kinase.

uPAR Antibody / uPA Receptor

R32759 100ug
EUR 356.15
Description: PLAUR (Plasminogen Activator Receptor, Urokinase-Type), also known as UPAR (uPA Receptor) or CD87, is multidomain glycoprotein tethered to the cell membrane with a glycosylphosphotidylinositol (GPI) anchor. PLAUR consists of three different domains of the Ly-6/uPAR/alpha-neurotoxin family. PLAUR is originally identified as a saturable binding site for urokinase on the cell surface. And the gene plays an important role in many normal as well as pathologic processes. The PLAUR gene is localized to 19q13.31. PLAUR is a part of the plasminogen activation system, which in the healthy body is involved in tissue reorganization events such as mammary gland involution and wound healing. PLAUR binds urokinase and thus restricts plasminogen activation to the immediate vicinity of the cell membrane. Thus it seems to be an important player in the regulation of this process. In human coronary artery vascular smooth muscle cells, UPA stimulates cell migration via a UPAR signaling complex containing TYK2 and phosphatidylinositol 3-kinase.

uPAR Antibody / uPA Receptor

RQ6957 100 ug
EUR 356.15
Description: PLAUR (PLASMINOGEN ACTIVATOR RECEPTOR, UROKINASE-TYPE), also known as UPAR or CD87, is multidomain glycoprotein tethered to the cell membrane with a glycosylphosphotidylinositol (GPI) anchor. PLAUR consists of three different domains of the Ly-6/uPAR/alpha-neurotoxin family. PLAUR is originally identified as a saturable binding site for urokinase on the cell surface. And the gene plays an important role in many normal as well as pathologic processes. The PLAUR gene is localized to 19q13.31. PLAUR is a part of the plasminogen activation system, which in the healthy body is involved in tissue reorganization events such as mammary gland involution and wound healing. PLAUR binds urokinase and thus restricts plasminogen activation to the immediate vicinity of the cell membrane. Thus it seems to be an important player in the regulation of this process. In human coronary artery vascular smooth muscle cells, UPA stimulates cell migration via a UPAR signaling complex containing TYK2 and phosphatidylinositol 3-kinase.

uPAR Antibody / uPA Receptor

RQ4361 100 ug
EUR 356.15
Description: PLAUR (Plasminogen activator receptor, urokinase-type), also known as UPAR or CD87, is multidomain glycoprotein tethered to the cell membrane with a glycosylphosphotidylinositol (GPI) anchor. PLAUR consists of three different domains of the Ly-6/uPAR/alpha-neurotoxin family. PLAUR is originally identified as a saturable binding site for urokinase on the cell surface. And the gene plays an important role in many normal as well as pathologic processes. The PLAUR gene is localized to 19q13.31. PLAUR is a part of the plasminogen activation system, which in the healthy body is involved in tissue reorganization events such as mammary gland involution and wound healing. PLAUR binds urokinase and thus restricts plasminogen activation to the immediate vicinity of the cell membrane. Thus it seems to be an important player in the regulation of this process. In human coronary artery vascular smooth muscle cells, UPA stimulates cell migration via a UPAR signaling complex containing TYK2 and phosphatidylinositol 3-kinase.

uPAR Antibody / uPA Receptor

RQ4654 100ug
EUR 356.15
Description: PLAUR (PLASMINOGEN ACTIVATOR RECEPTOR, UROKINASE-TYPE), also known as UPAR or CD87, is multidomain glycoprotein tethered to the cell membrane with a glycosylphosphotidylinositol (GPI) anchor. PLAUR consists of three different domains of the Ly-6/uPAR/alpha-neurotoxin family. PLAUR is originally identified as a saturable binding site for urokinase on the cell surface. And the gene plays an important role in many normal as well as pathologic processes. The PLAUR gene is localized to 19q13.31. PLAUR is a part of the plasminogen activation system, which in the healthy body is involved in tissue reorganization events such as mammary gland involution and wound healing. PLAUR binds urokinase and thus restricts plasminogen activation to the immediate vicinity of the cell membrane. Thus it seems to be an important player in the regulation of this process. In human coronary artery vascular smooth muscle cells, UPA stimulates cell migration via a UPAR signaling complex containing TYK2 and phosphatidylinositol 3-kinase.

Rat UPA ELISA Kit

ERU0019 96Tests
EUR 625.2

Goat UPA ELISA Kit

EGTU0019 96Tests
EUR 625.2

Human UPA ELISA Kit

EHU0019 96Tests
EUR 625.2

Human uPA ELISA Kit

55R-1696 1 kit
EUR 617
Description: ELISA kit for detection of uPA in the research laboratory

Human uPA ELISA Kit

ELA-E1308h 96tests
EUR 696

Sheep UPA ELISA Kit

ESU0019 96Tests
EUR 625.2

Mouse UPA ELISA Kit

EMU0019 96Tests
EUR 625.2

Human uPA ELISA kit

LF-EK50397 1×96T
EUR 777.6

Human uPA ELISA Kit

MBS825102-5x96Tests 5x96Tests
EUR 2880

Human uPA ELISA Kit

MBS825102-96Tests 96Tests
EUR 645

uPA Human ELISA Kit

MBS355427-5x96Tests 5x96Tests
EUR 2190

uPA Human ELISA Kit

MBS355427-96Tests 96Tests
EUR 485

Bovine UPA ELISA Kit

EBU0019 96Tests
EUR 625.2

Canine UPA ELISA Kit

ECU0019 96Tests
EUR 625.2

Rabbit UPA ELISA Kit

ERTU0019 96Tests
EUR 625.2

Monkey UPA ELISA Kit

EMKU0019 96Tests
EUR 625.2

Chicken UPA ELISA Kit

ECKU0019 96Tests
EUR 625.2

Porcine UPA ELISA Kit

EPU0019 96Tests
EUR 625.2

Anserini UPA ELISA Kit

EAU0019 96Tests
EUR 625.2

Anti Murine uPA (capture)

MBS480192-1mg 1mg
EUR 1105

Anti Murine uPA (capture)

MBS480192-5x1mg 5x1mg
EUR 4760

Anti Human uPA antiserum

MBS480187-1mL 1mL
EUR 650

Anti Human uPA antiserum

MBS480187-5x1mL 5x1mL
EUR 2710

Anti-Human uPA Antibody

101-M697 100 µg
EUR 399
Description: u-Plasminogen Activator (uPA) is a serine protease that converts plasminogen to plasmin, with roles in a variety of normal and pathological processes that include cell migration and tissue destruction. uPA is a potent marker of invasion and metastasis in a variety of human cancers including breast, stomach, colon, bladder, ovarian, brain, and endometrium.

Rat Urokinase (uPA) Antibody

12172-05011 150 ug
EUR 175

Urokinase Antibody (UPA, Plau)

F51093-0.08ML 0.08 ml
EUR 140.25
Description: PLAU, a member of the peptidase family S1, is a potent plasminogen activator and is clinically used for therapy of thrombolytic disorders. PLAU specifically cleaves the Arg-|-Val bond in plasminogen to form plasmin. The protein is found in high and low molecular mass forms. Each consists of two chains, A and B. The high molecular mass form contains a long chain A. Cleavage occurs after residue 155 in the low molecular mass form to yield a short A1 chain. The protein is used in Pulmonary Embolism (PE) to initiates fibrinolysis. Structurally, PLAU contains 1 EGF-like domain and 1 kringle domain.

Urokinase Antibody (UPA, Plau)

F51094-0.08ML 0.08 ml
EUR 140.25
Description: PLAU, a member of the peptidase family S1, is a potent plasminogen activator and is clinically used for therapy of thrombolytic disorders. PLAU specifically cleaves the Arg-|-Val bond in plasminogen to form plasmin. The protein is found in high and low molecular mass forms. Each consists of two chains, A and B. The high molecular mass form contains a long chain A. Cleavage occurs after residue 155 in the low molecular mass form to yield a short A1 chain. The protein is used in Pulmonary Embolism (PE) to initiates fibrinolysis. Structurally, PLAU contains 1 EGF-like domain and 1 kringle domain.

Urokinase Antibody (UPA, Plau)

F52084-0.08ML 0.08 ml
EUR 140.25
Description: Specifically cleave the zymogen plasminogen to form the active enzyme plasmin.

Urokinase Antibody / uPA / PLAU

RQ4847 100ul
EUR 356.15
Description: 'Urokinase-type plasminogen activator' specifically cleaves the zymogen plasminogen to form the active enzyme plasmin. [UniProt]

Urokinase Antibody / uPA / PLAU

RQ4217 100 ug
EUR 356.15
Description: Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. This gene encodes a secreted serine protease that converts plasminogen to plasmin. The encoded preproprotein is proteolytically processed to generate A and B polypeptide chains. These chains associate via a single disulfide bond to form the catalytically inactive high molecular weight urokinase-type plasminogen activator (HMW-uPA). HMW-uPA can be further processed into the catalytically active low molecular weight urokinase-type plasminogen activator (LMW-uPA). This low molecular weight form does not bind to the urokinase-type plasminogen activator receptor. Mutations in this gene may be associated with Quebec platelet disorder and late-onset Alzheimer's disease. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed.

PLAU / uPA Recombinant Protein

11-306 0.05 mg
EUR 714.3
Description: Urokinase - type plasminogen activator is also known as PLAU and UPA, a serine protease with an extremely limited substrate specificity, cleaving the sequence Cys – Pro – Gly - Arg560 - Val561 – Val – Gly – Gly – Cys in plasminogen to form plasmin. uPA is a potent marker of invasion and metastasis in a variety of human cancers associated with breast, stomach, colon, bladder, ovary, brain and endometrium.uPA and its receptor (uPAR) have been implicated in a broad spectrum of pathophysiological processes, including fibrinolysis, proteolysis, inflammation, atherogenesis and plaque destabilization, all of which are involved in the pathogenesis of MI (myocardial infarction).

Human Urokinase (uPA) Antibody

11651-05011 150 ug
EUR 175

OACD08148-1ML - UPA Antibody

OACD08148-1ML 1ml
EUR 659

Mouse monoclonal uPA antibody

MBS5307661-04mL 0.4mL
EUR 2205

Mouse monoclonal uPA antibody

MBS5307661-5x04mL 5x0.4mL
EUR 9770

Mouse monoclonal uPA antibody

MBS5307662-04mL 0.4mL
EUR 2205

Mouse monoclonal uPA antibody

MBS5307662-5x04mL 5x0.4mL
EUR 9770

Mouse monoclonal uPA antibody

MBS5307663-04mL 0.4mL
EUR 2205

Mouse monoclonal uPA antibody

MBS5307663-5x04mL 5x0.4mL
EUR 9770

Mouse monoclonal uPA antibody

MBS5307664-04mL 0.4mL
EUR 2205

Mouse monoclonal uPA antibody

MBS5307664-5x04mL 5x0.4mL
EUR 9770

uPA Rabbit Polyclonal Antibody

ES6602-100ul 100ul
EUR 124
Description: A Rabbit Polyclonal antibody against uPA from Human. This antibody is tested and validated for IHC, WB, ELISA

uPA Rabbit Polyclonal Antibody

ES6602-50ul 50ul
EUR 74
Description: A Rabbit Polyclonal antibody against uPA from Human. This antibody is tested and validated for IHC, WB, ELISA

OACD08148-100UL - UPA Antibody

OACD08148-100UL 100ul
EUR 189

OAAF06011-100UG - uPA Antibody

OAAF06011-100UG 100ug
EUR 329

Urokinase Plasminogen Activator (uPA)

MBS6508427-01mg 0.1mg
EUR 910

Urokinase Plasminogen Activator (uPA)

MBS6508427-5x01mg 5x0.1mg
EUR 3950

Urokinase Plasminogen Activator (uPA)

MBS6508428-01mg 0.1mg
EUR 860

Urokinase Plasminogen Activator (uPA)

MBS6508428-5x01mg 5x0.1mg
EUR 3725

Rat PLAU/uPA ELISA Kit

EF017990 96tests
EUR 566

uPA-R Human ELISA Kit

MBS355336-5x96Tests 5x96Tests
EUR 2190

uPA-R Human ELISA Kit

MBS355336-96Tests 96Tests
EUR 485

Anti Rat uPA (High Titer)

MBS480331-01mg 0.1mg
EUR 825

Anti Rat uPA (High Titer)

MBS480331-5x01mg 5x0.1mg
EUR 3490

uPA Receptor/U-PAR Rabbit pAb

E2121140 100 μl
EUR 225
Description: Available in various conjugation types.

uPA Receptor/U-PAR Rabbit pAb

E2821140 100 μl
EUR 225
Description: Available in various conjugation types.

uPA Receptor/U-PAR Rabbit pAb

MBS8574929-01mL 0.1mL
EUR 305

uPA Receptor/U-PAR Rabbit pAb

MBS8574929-01mLAF405L 0.1mL(AF405L)
EUR 465

uPA Receptor/U-PAR Rabbit pAb

MBS8574929-01mLAF405S 0.1mL(AF405S)
EUR 465

uPA Receptor/U-PAR Rabbit pAb

MBS8574929-01mLAF610 0.1mL(AF610)
EUR 465

uPA Receptor/U-PAR Rabbit pAb

MBS8574929-01mLAF635 0.1mL(AF635)
EUR 465

uPA Receptor/U-PAR Rabbit pAb

MBS8574930-01mL 0.1mL
EUR 305

uPA Receptor/U-PAR Rabbit pAb

MBS8574930-01mLAF405L 0.1mL(AF405L)
EUR 465

uPA Receptor/U-PAR Rabbit pAb

MBS8574930-01mLAF405S 0.1mL(AF405S)
EUR 465

uPA Receptor/U-PAR Rabbit pAb

MBS8574930-01mLAF610 0.1mL(AF610)
EUR 465

uPA Receptor/U-PAR Rabbit pAb

MBS8574930-01mLAF635 0.1mL(AF635)
EUR 465

Guinea Pig UPA ELISA Kit

EGU0019 96Tests
EUR 625.2

Human uPA/PLAU ELISA Kit

EK5228 96 tests
EUR 599

Human PLAU/uPA ELISA KIT

EF000376 96tests
EUR 566

Mouse PLAU/Upa ELISA Kit

EF013009 96tests
EUR 566

Human uPA/PLAU ELISA Kit

GWB-ZZD095 1x96 well plate Ask for price

Human PLAU/uPA ELISA Kit

IHUPLAUKT each
EUR 548
Description: Human PLAU/uPA ELISA Kit

Mouse PLAU/uPA ELISA Kit

IMSPLAUKT each
EUR 548
Description: Mouse PLAU/uPA ELISA Kit

Sheep Anti Human uPA IgG

MBS480333-1mg 1mg
EUR 455

Sheep Anti Human uPA IgG

MBS480333-5x1mg 5x1mg
EUR 1830

*Human PAI-1 uPA Complex

IHUPAI1UPACX100UG each
EUR 422
Description: *Human PAI-1 uPA Complex

*Human PAI-1 uPA Complex

IHUPAI1UPACX1MG each
EUR 3330
Description: *Human PAI-1 uPA Complex

Rabbit PLAU/uPA ELISA Kit

IRBPLAUUPAKT each
EUR 614
Description: Rabbit PLAU/uPA ELISA Kit

Human uPA ELISA kit (4X96T)

LF-EK50398 4×96T
EUR 2641.2

Human PAI-1 uPA complex

MBS135648-01mg 0.1mg
EUR 620

Human PAI-1 uPA complex

MBS135648-1mg 1mg
EUR 4155

Human PAI-1 uPA complex

MBS135648-5x1mg 5x1mg
EUR 18470

Human UPA Protein, His Tag

MBS188792-001mg 0.01mg
EUR 235

Human UPA Protein, His Tag

MBS188792-005mg 0.05mg
EUR 435

Human UPA Protein, His Tag

MBS188792-5x005mg 5x0.05mg
EUR 1655

Anti Mouse uPA (High Titer)

MBS480328-01mg 0.1mg
EUR 825

Anti Mouse uPA (High Titer)

MBS480328-5x01mg 5x0.1mg
EUR 3490

Human PAI-1 uPA Complex

MBS480716-01mg 0.1mg
EUR 610

Human PAI-1 uPA Complex

MBS480716-5x01mg 5x0.1mg
EUR 2530

Anti Human uPA IgG fraction

MBS480188-1mg 1mg
EUR 650

Anti Human uPA IgG fraction

MBS480188-5x1mg 5x1mg
EUR 2710

Sheep anti dog uPA antiserum

MBS135172-01mL 0.1mL
EUR 430

Sheep anti dog uPA antiserum

MBS135172-10mL 10mL
EUR 3560

Sheep anti dog uPA antiserum

MBS135172-1mL 1mL
EUR 650

Sheep anti dog uPA antiserum

MBS135172-5x10mL 5x10mL
EUR 15795

Anti Mouse & Rat uPA antiserum

MBS480324-1mL 1mL
EUR 545

Anti Mouse & Rat uPA antiserum

MBS480324-5x1mL 5x1mL
EUR 2235

Sheep Anti Dog uPA antiserum

MBS480336-1mL 1mL
EUR 585

Sheep Anti Dog uPA antiserum

MBS480336-5x1mL 5x1mL
EUR 2415

Rat uPA activity ELISA assay

MBS480481-1Kit 1Kit
EUR 825

Rat uPA activity ELISA assay

MBS480481-5x1Kit 5x1Kit
EUR 3755

Human Urokinase/uPA ELISA Kit

E28L0631 96T
EUR 666.67

*Human Urokinase (uPA) ELISA Kit

IHUUPAKT each
EUR 528
Description: *Human Urokinase (uPA) ELISA Kit

uPA ELISA Kit (Human) (OKBB00267)

OKBB00267 96 Tests
EUR 606
Description: Description of target: Plasminogen activator,urokinase (PLAU, uPA) converts plasminogen to plasmin. Plasmin is involved in processing of amyloid precursor protein and degrades secreted and aggregated amyloid-beta, a hallmark of Alzheimer disease (AD). Urokinase has a molecular mass of about 54 kD and is composed of 2 disulfide-linked chains, A and B, of molecular masses 18 kD and 33 kD, respectively. It localized on 10q24. uPA facilitates cell migration by localizing proteolisys on the cell surface and by inducing intracellular signalling pathways. In human vascular smooth muscle cell (VSMC), uPA stimulates migration via the uPA receptor (uPAR) signalling complex containing TYK2 and phosphatidylinositol 3-kinase (PI3-K).;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: < 5 pg/mL

Anti-Human uPA Affinity Pur.

MBS480191-01mg 0.1mg
EUR 790

Anti-Human uPA Affinity Pur.

MBS480191-5x01mg 5x0.1mg
EUR 3315

Mouse monoclonal to human uPA

MBS480371-1mg 1mg
EUR 735

Mouse monoclonal to human uPA

MBS480371-5x1mg 5x1mg
EUR 3110

Mouse monoclonal to human uPA

MBS480372-1mg 1mg
EUR 735

Mouse monoclonal to human uPA

MBS480372-5x1mg 5x1mg
EUR 3110

UPA ELISA Kit (Cattle) (OKCD04432)

OKCD04432 96 Wells
EUR 1123.2
Description: Description of target: ;Species reactivity: Cattle;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.061 ng/mL

Sheep anti mouse uPA antiserum

MBS135163-01mL 0.1mL
EUR 340

Sheep anti mouse uPA antiserum

MBS135163-10mL 10mL
EUR 2405

Sheep anti mouse uPA antiserum

MBS135163-1mL 1mL
EUR 500

Sheep anti mouse uPA antiserum

MBS135163-5x10mL 5x10mL
EUR 10595

Sheep anti human uPA antiserum

MBS135481-01mL 0.1mL
EUR 340

Sheep anti human uPA antiserum

MBS135481-10mL 10mL
EUR 2405

Sheep anti human uPA antiserum

MBS135481-1mL 1mL
EUR 500

Sheep anti human uPA antiserum

MBS135481-5x10mL 5x10mL
EUR 10595

Sheep Anti Human uPA antiserum

MBS480332-1mL 1mL
EUR 455

Sheep Anti Human uPA antiserum

MBS480332-5x1mL 5x1mL
EUR 1830

Canine Urokinase(uPA) ELISA Kit

EIA06502Ca each
EUR 520

*Mouse Urokinase (uPA) HIS Labeled

IMSUPAHIS100UG each
EUR 635
Description: *Mouse Urokinase (uPA) HIS Labeled

*Mouse Urokinase (uPA) HIS Labeled

IMSUPAHIS1MG each
EUR 4796
Description: *Mouse Urokinase (uPA) HIS Labeled

Rabbit anti mouse uPA antiserum

MBS135122-01mL 0.1mL
EUR 340

Rabbit anti mouse uPA antiserum

MBS135122-10mL 10mL
EUR 3605

Rabbit anti mouse uPA antiserum

MBS135122-1mL 1mL
EUR 490

Rabbit anti mouse uPA antiserum

MBS135122-5x10mL 5x10mL
EUR 15990

Rabbit anti human uPA antiserum

MBS135358-10mL 10mL
EUR 3735

Rabbit anti human uPA antiserum

MBS135358-1mL 1mL
EUR 560

Rabbit anti human uPA antiserum

MBS135358-5x10mL 5x10mL
EUR 16575

Sheep Anti Rabbit uPA antiserum

MBS135365-01mL 0.1mL
EUR 355

Suppression of the inflammatory response by prostaglandin E2 expression Upar debilitating treatment. Despite this relationship, H. pylori does not induce the expression of Upar in vitro in cells co-cultured with gastric cancer; (4) Conclusion: We showed that persistent H. pylori colonization is an important event for the emergence of a relatively high Upar protein expression in murine gastric epithelial cells.

Dustin

Related Posts

Comparison of intrapleural use of urokinase and tissue plasminogen activator/DNAse in pleural infection.

Comparison of intrapleural use of urokinase and tissue plasminogen activator/DNAse in pleural infection.

Serum plasminogen activator urokinase receptor predicts elevated risk of acute respiratory distress syndrome in patients with sepsis and is positively associated with disease severity, inflammation and mortality.

Serum plasminogen activator urokinase receptor predicts elevated risk of acute respiratory distress syndrome in patients with sepsis and is positively associated with disease severity, inflammation and mortality.

Comparative study on the efficacy and safety of alteplase and urokinase in the treatment of acute cerebral infarction

Comparative study on the efficacy and safety of alteplase and urokinase in the treatment of acute cerebral infarction

Independent impact of periodontitis and cardiovascular disease on elevated soluble urokinase-type plasminogen activator receptor levels

Independent impact of periodontitis and cardiovascular disease on elevated soluble urokinase-type plasminogen activator receptor levels

No Comment

Leave a Reply

Your email address will not be published.

June 2024
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930

Recent Posts

Categories

Tags